Resources Contact Us Home
Modified factor VIII

Image Number 6 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Semiconductor device and method of forming interconnect structure with conductive pads having expanded interconnect surface area for enhanced interconnection properties
Integrated multi-sat LNB and frequency translation module
Defensin polynucleotides and methods of use
Apparatus and method for providing vehicle data for testing product
Content reproduction apparatus and content processing method therefor
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Method for manufacturing photoelectric conversion device
  Randomly Featured Patents
Multicoated steel sheet susceptible to cationic electrodeposition coating
Steiner tree handling device, Steiner tree handling method, and Steiner tree handling program
Hydraulic dual-circuit brake system with anti-skid and traction control
Pyramid clip
System for injecting gas into a detonation projection gun
Flow compensated proportional bypass valve combined with a control valve
Encapsulated surface acoustic wave component and method of collective fabrication
Decolorising of whey and products derived from whey
Non-attached electronic monitoring device for tire